Literature DB >> 12130458

Positive [11C]choline and negative [18F]FDG with positron emission tomography in recurrence of prostate cancer.

M Picchio1, C Landoni, C Messa, L Gianolli, M Matarrese, F De Cobelli, A Del Maschio, F Fazio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12130458     DOI： 10.2214/ajr.179.2.1790482

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN： 0361-803X            Impact factor:   3.959


× No keyword cloud information.
  7 in total

1.  [11C]Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: comparison with bone scintigraphy.

Authors:  Maria Picchio; Elena Giulia Spinapolice; Federico Fallanca; Cinzia Crivellaro; Giampiero Giovacchini; Luigi Gianolli; Cristina Messa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-09-20       Impact factor: 9.236

2.  Is 11C-choline the most appropriate tracer for prostate cancer? For.

Authors:  Ferruccio Fazio; Maria Picchio; Cristina Messa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-04-02       Impact factor: 9.236

3.  Is 11C-choline the most appropriate tracer for prostate cancer? Against.

Authors:  Klaus Zöphel; Jörg Kotzerke
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-04-02       Impact factor: 9.236

Review 4.  [Impact of nuclear medicine imaging techniques for lymph node surgery].

Authors:  L S Freudenberg; G Holl; S P Müller; S J Rosenbaum-Krumme; J Sciuk; A Bockisch
Journal:  Urologe A       Date:  2009-01       Impact factor: 0.639

Review 5.  [Value of imaging for lymph node metastases from renal cell, bladder, prostate, penile, and testicular cancers].

Authors:  J Stattaus; A Bockisch; M Forsting; S P Müller
Journal:  Urologe A       Date:  2005-06       Impact factor: 0.639

Review 6.  Functional imaging for prostate cancer: therapeutic implications.

Authors:  Carina Mari Aparici; Youngho Seo
Journal:  Semin Nucl Med       Date:  2012-09       Impact factor: 4.446

Review 7.  Positron Emission Tomography (PET) radiotracers in oncology--utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC).

Authors:  Evelina Miele; Gian Paolo Spinelli; Federica Tomao; Angelo Zullo; Filippo De Marinis; Giulia Pasciuti; Luigi Rossi; Federica Zoratto; Silverio Tomao
Journal:  J Exp Clin Cancer Res       Date:  2008-10-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.